AstraZeneca of Waltham, Mass., has named James Fickett global director of bioinformatics. From 1980 to 1996 Fickett was a member of the T-10 theoretical biology and biophysics group at Los Alamos National Laboratory, where he co-founded GenBank. He most recently served as director of bioinformatics research at GlaxoSmithKline.
Fickett will be based in Waltham and will oversee the companys core bioinformatics groups in Boston, Wilmington, Del., and Alderley Park, UK. He reports to Kenneth Fasman, vice president and global head of R&D informatics.
Daniel Masys, associate clinical professor of medicine and director of biomedical informatics for the University of California, San Diego, School of Medicine, was elected an active member in the Institute of Medicine, part of the National Academy of Sciences.
Masys research interests include Internet-accessible medical records and health information, Internet utilities for conducting clinical research, and the analytical informatics of gene expression profiling using microarray technologies.
In January 2002, Stephan Burley will join San Diego-based Structural GenomiX as CSO and senior vice president of R&D.
Burley is the deputy for academic affairs at Rockefeller University, where he directs the Pels Family Center for Biochemistry and Structural Biology. He is a full investigator with the Howard Hughes Medical Institute and serves as the principal investigator of the New York Structural Genomics Research Consortium.
Burley was a co-founder of Prospect Genomics, a company acquired by SGX earlier this year, and was an original member of SGXs scientific advisory board.